RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.12), $0.17 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $27.56 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.